LAVA Therapeutics NV LVTX

Business address

Utrecht

State

Outside the U.S. or not given

Incorporated in

Outside the U.S. or not given

Industry

Manufacturing (SIC 2834)

SEC CIK

1840748

Accession number

0001104659-25-110913

Items reported in this filing

• Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

  An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.

• Item 5.01 Changes in Control of Registrant
• Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
• Item 9.01 Financial Statements and Exhibits

Other entries on the wire for this company

1. 21Nov 2025

   Listing notice

   LAVA Therapeutics NV LVTX

   Utrecht Manufacturing Form 8-K, items 2.01, 3.01, 3.03, 5.02

   SEC filing for LAVA Therapeutics NV (opens in a new tab)
2. 28Feb 2025

   Listing notice

   LAVA Therapeutics NV LVTX

   Utrecht, P7 Manufacturing Form 8-K, items 3.01

   SEC filing for LAVA Therapeutics NV (opens in a new tab)
3. 25Feb 2025

   Restructuring (Item 2.05)

   LAVA Therapeutics NV LVTX

   Utrecht, P7 Manufacturing Form 8-K, items 2.05, 7.01, 9.01

   SEC filing for LAVA Therapeutics NV (opens in a new tab)

Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing